Skip to main content

Table 1 Characteristics of children started on antiretroviral treatment ( n= 26)

From: Clinical, immunological, and virological outcomes of pediatric antiretroviral therapy in central China

Characteristics

Numbers(interval)

Percentage

Age at start ART (years, median)a

7.7 (1.5–12)

 

<2 years

2

7.7%

2–4.9 years

4

15.3%

5–14 years

20

77%

Sex (male/female)

16/10

61.5%/38.5%

Reason for ART

  

WHO stage III-IV

6

36.5%

Baseline CD4 count <15%

20

63.5%

Naïve ART regimen

  

D4T/3TC/NVP (EFV)

8

30.8%

AZT/3TC/NVP

18

69.2%

Time on ART (months, median)a,b

41 (18–72.3)

 

<2 yearsb

5

19.2%

2 years to <3 yearsb

7

26.9%

3 years to <4 yearsb

6

23.1%

>4 yearsb

8

30.8%

HIV transmission

  

Blood product or transfusion recipient

9

34.6%

Mother-to-child transmission

17

65.4%

  1. aValues are expressed as median (interquartile range).
  2. bAs of 30 December 2008 (closing date of dataset).
  3. WHO, World Health Organization; ART, antiretroviral therapy; D4T, stavudine; 3TC, lamivudine; AZT, zidovudine;NVP, nevirapine; EFV, efavirenz.